Nordic Bioscience Welcomes Investment decision from KKR for Future Section of Advancement

COPENHAGEN–(Enterprise WIRE)–Nordic Bioscience A/S, a Danish firm and entire world leader in biomarker development, introduced nowadays the signing of an expense from KKR, a main global investment decision agency. KKR will acquire a minority equity stake in Nordic Bioscience from existing shareholders and will support the organization in accelerating its global progress.

Nordic Bioscience has globe-major awareness and ownership of biomarkers, measurable indicators of biological transform or reaction utilised for the improvement of diagnostic instruments and identification of new drug candidates.

“I am thrilled to welcome KKR as a valued trader to the Nordic Bioscience crew and to have their assistance in constructing on our method of bringing innovative novel diagnostic biomarkers and drug candidates to the sector for the gain of people. Our speedy-relocating customers have high anticipations, and KKR’s financial commitment will propel Nordic Bioscience forward so that we can continue to meet up with these anticipations. At the main of Nordic Bioscience is collaboration, among the our group, with our partners and consumers and now with KKR,” reported Morten Karsdal, CEO of Nordic Bioscience.

Nordic Bioscience has set up a placement as the world’s most expert organization within just the extracellular matrix (ECM) by way of additional than 25 years of dedicated investigate and progress. The ECM is the non-cellular ingredient of all tissues and organs and can be analyzed to establish new drug candidates in a lot more than 50 condition locations, diagnose individuals and consider the impact of existing medicine and drug candidates.

Nordic Bioscience owns a lot more than 150 patents and has revealed over 500 scientific papers in leading scientific journals. The firm has entered into partnerships with the world’s premier pharma corporations to acquire new medications in four big disorder spots (fibrosis, oncology, diabetic issues and cardiovascular) and has collaborations with major diagnostic firms for the use of Nordic Bioscience’s biomarkers for diagnostic applications. In addition, Nordic Bioscience solutions a increasing intercontinental client base of pharma, biotech and CROs with preclinical and medical knowledge analysis from its licensed laboratory.

“On the foundation of our outstanding information of the ECM, we are a sought-soon after associate to the world’s major worldwide overall health care companies and now have a base to accelerate our intercontinental enhancement,” mentioned Morten Karsdal.

KKR is a main global investment agency deeply fully commited to responsible expenditure, with a dedicated concentration on health and fitness care expansion and on partnering with foremost companies and management groups to build and increase wonderful enterprises.

“KKR has a strong keep track of report of supporting well being treatment corporations, and I glance ahead to leveraging KKR’s world wide network and experience across the pharma and broader drug advancement business to speed up the promising alternatives that we have to assist boost the lives of patients with persistent ailments,” stated Dr. Claus Christiansen, Founder & Chairman of Nordic Bioscience.

Given that its foundation in 1976, KKR has supported hundreds of corporations with their growth ambitions. With additional than 200 portfolio organizations currently and 21 offices all over the planet, KKR has a truly global financial investment standpoint.

“We feel strongly in Nordic Bioscience’s vision to enable sufferers globally by supporting the enhancement of biomarkers and appear forward to supporting Nordic Bioscience achieve its bold strategies for progress and intercontinental growth,” claimed Kugan Sathiyanandarajah, Managing Director at KKR and Head of Europe for KKR’s Wellbeing Treatment Strategic Expansion investing initiatives, and Anuv Ratan, Principal at KKR.

KKR will help speed up Nordic Bioscience’s worldwide expansion.

“We are in a exceptional position to capitalize on the ECM knowledge and leadership that we have formulated above the earlier 25 a long time and know far more than any other organization about the ECM. I am confident that we will perform an vital part in the development of new prescription drugs targeted at 2-3 big illness regions in the coming several years. With KKR, we have located the suitable trader to aid us commercialize our information,” mentioned Dr. Claus Christiansen.

“We are extremely impressed with Nordic Bioscience, its special scientific heritage and exceptional group. We are on the lookout ahead to doing the job collectively with Claus, Morten and the team to speed up the advancement of the organization. The financial investment in Nordic Bioscience is a very good illustration of how KKR combines its local geographic franchises with deep perception from its sector teams,” stated Anders Borg, Managing Director at KKR.

KKR is producing the investment decision by way of the firm’s Wellbeing Care Strategic Growth Fund, which is focused on investing in foremost superior-development health care firms for which KKR can be a exclusive associate in aiding get to whole prospective. KKR has invested somewhere around $14 billion in equity money throughout the wellbeing treatment sector considering that 2004. The Nordic Bioscience investment decision is a further testament to KKR’s dedication to the Nordics, pursuing new investments throughout the region in Visma, Välinge, Mehilainen, Sector Alarm and Söderberg & Associates.

KKR and Nordic Bioscience is a potent match.

The company finance boutique Nordic M&A advised Nordic Bioscience on the transaction. “Everyone wished to spouse with Nordic Bioscience thanks to its proprietary ECM understanding, and anyone wishes to companion with KKR due to its exceptional global industrial competencies and resources. The mixture of the two is a incredibly sturdy match – two leaders in their respective fields,” claimed Anders W. Eriknauer, Running Spouse of Nordic M&A.

-ends-

About Dr. Claus Christiansen

Dr. Claus Christiansen, with each other with his wife Dr. Bente Juel Riis, has through the final three decades launched and been associated with many productive biotechnology providers, together with amongst other folks Osteometer, CCBR Synarc, Sanos Clinic, and Radius Wellness in addition to Nordic Bioscience. Dr. Christiansen is also the founder of Danish Investigation Foundation, which has dispersed additional than 250 million DKK to existence science and pure sciences exploration tasks, arts and tradition and other miscellaneous projects.

About KKR

KKR is a major global investment agency that offers option asset management and money marketplaces and coverage answers. KKR aims to crank out interesting expenditure returns by subsequent a client and disciplined expenditure tactic, using earth-class people and supporting expansion in its portfolio organizations and communities. KKR sponsors financial investment cash that commit in personal fairness, credit and serious property and has strategic companions that take care of hedge money. KKR’s insurance plan subsidiaries supply retirement, existence and reinsurance solutions below the administration of The Global Atlantic Money Group. References to KKR’s investments may possibly include things like the actions of its sponsored money and insurance plan subsidiaries. For more details about KKR & Co. Inc. (NYSE: KKR), be sure to pay a visit to KKR’s web site at www.kkr.com and on Twitter @KKR_Co.